Necrotizing fasciitis successfully treated with extracorporeal blood oxygenation and ozonization (EBOO)
Di Paolo N, Bocci V, Cappelletti F, et al. International Journal of Artificial Organs, 2002.
- Study type
- Case report
- People studied
- 1 person
- Population
- Dialysis patient with necrotizing fasciitis unresponsive to standard therapy
- Published
- 2002, International Journal of Artificial Organs
- Identifiers
- PMID 12518965, DOI 10.1177/039139880202501212
What the authors reported
A dialysis patient with necrotizing fasciitis who had not improved with traditional therapies improved radically after treatment with EBOO, which the authors describe as already used routinely at their hospital.
What limits this result
Single case report from the technique's own developers, read from a four-sentence abstract only. That abstract gives no outcome measure, follow-up, or procedure details such as the number of sessions or the ozone dose, and the case has no control patient.
Reports of the procedure as given to patients, and a review of them by its developers. Laboratory and device-development work on the circuit is under background science. One study rarely settles a medical question; our guides weigh each paper against the rest of the evidence.
How the study was done
- Design
- A case of necrotizing fasciitis in a dialysis patient is described
- Setting
- Department of Nephrology, Azienda Ospedaliera Senese, University of Siena, Siena, Italy
- Read from
- Read from the abstract only; where this page says nothing about an item, the abstract does not report it. Read on September 28, 2026.
Source: Abstract on PubMed
Study arms
| Group | Participants | What they received |
|---|---|---|
| Dialysis patient with necrotizing fasciitis | Not reported | Extracorporeal blood oxygenation and ozonation (EBOO), tried because traditional therapies were unsuccessful |
Source: Abstract on PubMed
What it measured
- Patient condition
- Improved radically after EBOO
Source: Abstract on PubMed
Where we cite this study
Does EBO2 (EBOO) Work? The Evidence, Study by Study
Every study in our EBO2 (EBOO) library in one place: design, size, what was measured and found, its limits, and a check for any study a clinic cites.
EBO2 (EBOO) vs Dialysis: How Ozone Dialysis Compares With Hemodialysis
EBO2 (EBOO), sold as ozone dialysis, set beside hemodialysis from primary sources: the filter, what flows past it, flow rates, FDA status, and the evidence.
The History of EBO2 (EBOO): A Dated Timeline From Siena to US Clinics
When and where EBO2 (EBOO) began, how it reached US clinics, and how regulators responded, as a dated timeline in which every entry cites its source.
How Many EBO2 (EBOO) Sessions Do You Need? What Clinics Recommend and What Studies Used
How many EBO2 (EBOO) sessions US clinics recommend, from our dataset of clinic pages, set against the course lengths published studies actually used.
EBO2 (EBOO) Side Effects and Safety: What Studies, Case Reports, and Regulators Record
What the EBOO studies record about side effects, the harms documented with other ozone procedures, the risks of the circuit, and what regulators have found.
What Is EBO2 (EBOO)? The Procedure, the Evidence, and What Regulators Say
What EBO2 (EBOO) is, step by step from the papers that introduced it, how the US clinic version differs, what regulators say, and what is still unknown.